Pelareorep Completed Phase 2 Trials for Non-Small Cell Lung Cancer (NSCLC) Treatment

Indications	Status	Purpose	Phase
DBCOND0034130 (Non-Small Cell Lung Cancer (NSCLC))	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT01708993	Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy	Docetaxel (DB01248) Pelareorep (DB17284) Pemetrexed (DB00642)